WASHINGTON: The White House said the ethical issues associated with gene-editing on the human genome need further study by the scientific community and should not be pursued until issues are resolved.
"The administration believes that altering the human germline for clinical purposes is a line that should not be crossed at this time," John Holdren, director of the White House Office of Science and Technology Policy, said in a statement.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!